连续罗哌卡因筋膜下伤口输注与鞘内吗啡用于剖宫产术后镇痛的比较:前瞻性随机对照双盲研究
该前瞻性随机对照双盲研究纳入192例择期剖宫产足月产妇,比较鞘内吗啡、连续罗哌卡因伤口输注与对照组的镇痛持续时间。结果显示鞘内吗啡(380分钟)和罗哌卡因伤口输注(351分钟)均较对照组(247分钟)延长镇痛时间,且不增加不良反应发生率。
要点
- 鞘内吗啡100μg与罗哌卡因0.2%伤口输注均延长剖宫产术后镇痛时间。
- 两种镇痛方式均降低术后累积吗啡消耗量且不良反应无差异。
- 罗哌卡因伤口输注可作为鞘内吗啡的替代镇痛方案。
核心结论
- 择期剖宫产术后,鞘内吗啡100μg和罗哌卡因伤口输注均延长镇痛持续时间并降低术后吗啡消耗,且不增加副作用发生率。
研究设计与样本
- 前瞻性、随机对照、双盲研究,纳入192例择期剖宫产足月产妇,随机分为对照组、吗啡组和导管组。
主要发现
- 镇痛持续时间:吗啡组380分钟(215-1527),导管组351分钟(227-594),对照组247分钟(182-338)。
- 效应量:吗啡组vs对照组0.171(0.043-0.293),导管组vs对照组0.164(0.052-0.271),吗啡组vs导管组0.007(-0.118至0.132)。
- 吗啡组和导管组术后累积吗啡消耗量均显著低于对照组,不良反应发生率组间无差异。
关键数值与推荐
- 鞘内注射吗啡100μg(0.1mL)或经伤口导管输注罗哌卡因0.2%,负荷量15mL后以10mL/h持续30小时。
- 所有患者接受包括对乙酰氨基酚和双氯芬酸的多模式镇痛。
临床怎么用
- 剖宫产术后可采用鞘内吗啡100μg或连续罗哌卡因0.2%伤口输注延长镇痛时间并减少阿片类药物消耗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: After cesarean delivery, postoperative pain management allows early rehabilitation and helps prevent postpartum depression and chronic pain. Our present prospective, randomized controlled, double-blind study assessed the duration and effect of intrathecal analgesia and continuous ropivacaine wound infiltration versus a control group after cesarean delivery. The primary outcome was analgesia duration, defined as time to first morphine request. Secondary outcomes were cumulative postoperative morphine consumption, number of patients who did not require IV morphine, incidence of adverse effects, and time to first ambulation. METHODS: A total of 192 full-term parturients undergoing elective cesarean delivery were randomly allocated into 3 groups (control, morphine, and catheter). All patients received spinal anesthesia with 10 mg bupivacaine 0.5% hyperbaric bupivacaine (2 mL) + 5 μg of sufentanil (1 mL) and a multiholed catheter inserted into the wound. In the control group, NaCl 0.9% was administered intrathecally (0.1 mL) and through the catheter. The morphine group received 100 μg morphine (0.1 mL) intrathecally and NaCl 0.9% infused through the wound catheter. The catheter group received 0.1 mL NaCl 0.9% intrathecally and ropivacaine 0.2% infused in the catheter. Each patient received a 15-mL bolus of the dedicated solution through the catheter, which was connected to an elastomeric pump infusor delivering the same solution at a rate of 10 mL/h for 30 hours. All patients also received multimodal analgesia including acetaminophen and diclofenac. Analgesia duration was defined as the time from spinal injection (T0) to first IV morphine requirement (T1) administered via a patient-controlled IV analgesia pump. Statistical data analyses included use of the Kruskal-Wallis rank-sum test followed by the post hoc Tukey test and χ test. RESULTS: The duration of postoperative analgesia was increased with intrathecal morphine (380 minutes; 215-1527) and ropivacaine wound infusion (351 minutes; 227-594) compared with the control (247 minutes; 182-338) with effect sizes of 0.171 (0.043-0.293) for morphine versus control and 0.164 (0.052-0.271) for catheter versus control. There was no difference between the morphine group and catheter group (effect size, 0.007; -0.118 to 0.132). Cumulative postoperative morphine consumption was also significantly lower in the morphine group and catheter group compared with the control group. The incidence of adverse effects did not differ between groups. CONCLUSIONS: After elective cesarean delivery, 100 μg intrathecal morphine and ropivacaine wound infusion both increased the duration and effect of postcesarean analgesia without increased incidence of side effects.
引用
- Lalmand M, Wilwerth M, Fils JF, et al. Continuous Ropivacaine Subfascial Wound Infusion Compared With Intrathecal Morphine for Postcesarean Analgesia: A Prospective, Randomized Controlled, Double-Blind Study. Anesth Analg. 2017. PMID: 28368941. doi:10.1213/ANE.0000000000001892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。